Personality Type as a Predictor to Develop Depression and Reduction in Quality of Life Among Stroke Survivals. - Full Text View

Personality Type as a Predictor to Develop Depression and Reduction in Quality of Life Among Stroke Survivals. (TPQ BDI SSQOL)

This study has been completed.

First Received on February 15, 2009. Last Updated on October 24, 2011 History of Changes

Sponsor:	d_yarnitsky
Information provided by (Responsible Party):	d_yarnitsky, Rambam Health Care Campus
ClinicalTrials.gov Identifier:	NCT00845455

Purpose

Personality type as a predictor to develop depression and reduction in quality of life among stroke survivals.

Condition
Stroke Depression Quality of Life Personality Type

Study Type:	Observational
Study Design:	Observational Model: Cohort Time Perspective: Prospective
Official Title:	Personality Type as a Predictor to Develop Depression and Reduction in Quality of Life Among Stroke Survivals.

Resource links provided by NLM:

MedlinePlus related topics: Depression

U.S. FDA Resources

Further study details as provided by Rambam Health Care Campus:

Primary Outcome Measures:

Depression [ Time Frame: 1-3 month post stroke ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

QOL post stroke [ Time Frame: 1-3 month post stroke ] [ Designated as safety issue: No ]

Enrollment:	85
Study Start Date:	November 2007
Study Completion Date:	June 2009
Primary Completion Date:	June 2009 (Final data collection date for primary outcome measure)

Groups/Cohorts
1. Harm Avoidance Personality type
2. Reward Dependence Personality type
3. Novelty Seeking Personality type

Eligibility

Ages Eligible for Study:	40 Years to 90 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Stroke ( TIA, CVA, ICH ) patients

Criteria

Inclusion Criteria:

any stroke,
age 40-90,
able to sigh informed concent,
able to fill in the questionnaires.

Exclusion Criteria:

non stroke,
previous depression,
not able to give consent or answer the questions.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00845455

Sponsors and Collaborators

d_yarnitsky

Investigators

Principal Investigator:

David - Yarnitsky, Prof.

More Information

No publications provided

Responsible Party:	d_yarnitsky, MD, Rambam Health Care Campus
ClinicalTrials.gov Identifier:	NCT00845455 History of Changes
Other Study ID Numbers:	TPQStroke03CTIL
Study First Received:	February 15, 2009
Last Updated:	October 24, 2011
Health Authority:	Israel: Ministry of Health

Additional relevant MeSH terms:

Personality Disorders
Depression
Depressive Disorder
Stroke
Cerebral Infarction
Mental Disorders
Behavioral Symptoms
Mood Disorders

Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases
Brain Infarction
Brain Ischemia

ClinicalTrials.gov processed this record on February 09, 2012